UK market access | pharmaphorum

Thursday 25 April 2024

Channels

Content type

Categories

Categories

Sort by

Order

UK market access

Sales & Marketing

pharmaphorum podcast episode 107a

Looking to the future of UK medical device exports

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industri

Market Access

Dr_Richard_Torbett_ABPI_Dec_2019_2

Global comparator data signal “alarm bells” for UK Governmen...

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

IQVIA Webinar

Sponsored

ICSs - an opportunity to improve Patient & Market Access at ...

With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in the UK are preparing to navigate the most significant piece of NHS legislation in

Views & Analysis

Perjeta

NHS England takes charge on market access

Today sees patients gain full NHS access to breast cancer drug Perjeta, a full six years on from its initial review by NICE.

News

MHRA logo1

BI drug named Promising Innovative Medicine in mesothelioma

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for one of its drugs.

News

Sanofi’s blockbuster-tipped Dupixent set for European launch...

Sanofi’s new atopic dermatitis treatment Dupixent has gained EU approval, setting it up for a launch across key European markets.